FR2780892B1 - Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique - Google Patents

Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique

Info

Publication number
FR2780892B1
FR2780892B1 FR9808730A FR9808730A FR2780892B1 FR 2780892 B1 FR2780892 B1 FR 2780892B1 FR 9808730 A FR9808730 A FR 9808730A FR 9808730 A FR9808730 A FR 9808730A FR 2780892 B1 FR2780892 B1 FR 2780892B1
Authority
FR
France
Prior art keywords
preparation
medicinal product
treating conditions
conditions resulting
membrane fixation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9808730A
Other languages
English (en)
Other versions
FR2780892A1 (fr
Inventor
Gregoire Prevost
Marie Odile Lonchampt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9808730A priority Critical patent/FR2780892B1/fr
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to CA002337261A priority patent/CA2337261A1/fr
Priority to JP2000558818A priority patent/JP2002520284A/ja
Priority to EP99929396A priority patent/EP1094810A1/fr
Priority to AU46224/99A priority patent/AU4622499A/en
Priority to PCT/FR1999/001611 priority patent/WO2000002558A1/fr
Publication of FR2780892A1 publication Critical patent/FR2780892A1/fr
Priority to NO20010030A priority patent/NO20010030L/no
Application granted granted Critical
Publication of FR2780892B1 publication Critical patent/FR2780892B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9808730A 1998-07-08 1998-07-08 Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique Expired - Fee Related FR2780892B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9808730A FR2780892B1 (fr) 1998-07-08 1998-07-08 Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique
JP2000558818A JP2002520284A (ja) 1998-07-08 1999-07-05 ヘテロ三量体状ｇプロテインの膜固定から生じる病気を処置する医薬の調製のためのプレニルトランスフェラーゼ抑制剤の使用
EP99929396A EP1094810A1 (fr) 1998-07-08 1999-07-05 Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique
AU46224/99A AU4622499A (en) 1998-07-08 1999-07-05 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric protein membrane fixation
CA002337261A CA2337261A1 (fr) 1998-07-08 1999-07-05 Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique
PCT/FR1999/001611 WO2000002558A1 (fr) 1998-07-08 1999-07-05 Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique
NO20010030A NO20010030L (no) 1998-07-08 2001-01-03 Anvendelse av prenyltransferase-inhibitorer for fremstilling av en medisin for behandling av patologier som stammer fra heterotrimer G-protein-membranfiksering

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9808730A FR2780892B1 (fr) 1998-07-08 1998-07-08 Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique

Publications (2)

Publication Number Publication Date
FR2780892A1 FR2780892A1 (fr) 2000-01-14
FR2780892B1 true FR2780892B1 (fr) 2001-08-17

Family

ID=9528404

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9808730A Expired - Fee Related FR2780892B1 (fr) 1998-07-08 1998-07-08 Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique

Country Status (7)

Country Link
EP (1) EP1094810A1 (fr)
JP (1) JP2002520284A (fr)
AU (1) AU4622499A (fr)
CA (1) CA2337261A1 (fr)
FR (1) FR2780892B1 (fr)
NO (1) NO20010030L (fr)
WO (1) WO2000002558A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420555B1 (en) * 1998-06-16 2002-07-16 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Imidazolyl derivatives
DE10235385B4 (de) * 2002-08-02 2006-10-05 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur chromatographischen Trennung von Komponenten
CA2522089A1 (fr) * 2003-04-30 2004-11-11 Consejo Superior De Investigaciones Cientificas Prevention d'une infection par le virus hiv-1 a travers l'inhibition de la reorganisation et/ou de l'alteration des domaines a reservoir de la membrane cellulaire induites par rho
JP4339739B2 (ja) 2004-04-26 2009-10-07 太陽誘電株式会社 部品内蔵型多層基板
CN114380848B (zh) * 2020-10-19 2023-03-14 华南农业大学 一种异喹啉并噻唑盐及其衍生物的制备与应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6909194A (en) * 1993-05-14 1994-12-12 Board Of Regents, The University Of Texas System Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole
EP0703905A1 (fr) * 1993-06-18 1996-04-03 Merck & Co. Inc. Inhibiteurs de farnesyle-proteine transferase
HUT77406A (hu) * 1994-03-15 1998-04-28 Eisai Co., Ltd., 1-(4-Amino-5-tio-pent-2-en)-il oldalláncot tartalmazó peptidomimetikumok és az ezeket tartalmazó gyógyszerkészítmények
US5523430A (en) * 1994-04-14 1996-06-04 Bristol-Myers Squibb Company Protein farnesyl transferase inhibitors
US5510510A (en) * 1994-05-10 1996-04-23 Bristol-Meyers Squibb Company Inhibitors of farnesyl protein transferase
US5491164A (en) * 1994-09-29 1996-02-13 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0794789A4 (fr) * 1995-01-12 1999-05-26 Univ Pittsburgh Inhibiteurs des prenyle transferases
US5534537A (en) * 1995-03-29 1996-07-09 Merck & Co., Inc. Prodrugs of inhibitors of farnesyl-protein transferase
US5627202A (en) * 1995-03-29 1997-05-06 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2226623A1 (fr) * 1995-07-13 1997-01-30 University Of Cincinnati Composes utiles dans le traitement des neurofibromatoses
TW349948B (en) * 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
AU7505196A (en) * 1995-11-07 1997-05-29 Banyu Pharmaceutical Co., Ltd. Cyclic amic acid derivatives
CA2238081A1 (fr) * 1995-11-22 1997-05-29 S. Jane Desolms Inhibiteurs de la farnesyl-proteine transferase
IL123568A (en) * 1995-12-08 2001-08-08 Janssen Pharmaceutica Nv History (Imidazole - 5Il) Methyl-2-quinolinone inhibitors of Prenzyl transferase, their preparation, pharmaceutical preparations containing them and their preparation and drugs containing them
EP0880320A4 (fr) * 1996-01-30 1999-06-16 Merck & Co Inc Inhibiteurs de la farnesyl-proteine transferase
JP2000504023A (ja) * 1996-04-03 2000-04-04 メルク エンド カンパニー インコーポレーテッド 癌治療方法
CA2250192A1 (fr) * 1996-04-03 1997-10-09 Chrisopher J. Dinsmore Inhibiteurs de farnesyle-proteine transferase
AU717298B2 (en) * 1996-04-03 2000-03-23 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1997038664A2 (fr) * 1996-04-18 1997-10-23 Merck & Co., Inc. Methode de traitement de cancer
US5773455A (en) * 1996-06-28 1998-06-30 Biomeasure, Incorporated Inhibitors of prenyl transferases

Also Published As

Publication number Publication date
EP1094810A1 (fr) 2001-05-02
NO20010030L (no) 2001-01-08
FR2780892A1 (fr) 2000-01-14
NO20010030D0 (no) 2001-01-03
CA2337261A1 (fr) 2000-01-20
JP2002520284A (ja) 2002-07-09
AU4622499A (en) 2000-02-01
WO2000002558A1 (fr) 2000-01-20

Similar Documents

Publication Publication Date Title
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
FR2717695B1 (fr) Système modulaire pour plateaux de stérilisation d'instruments chirurgicaux.
PT1338528E (pt) Utilização de um recipiente para um líquido medicinal
ATE254910T1 (de) Doppelkapsel zur verabreichung von arzneimitteln für vielfache therapien
HUP9701694A3 (en) Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds
HK1028033A1 (en) Sulfonamides for treatment of endothelin-mediated disorders.
DE69030825T2 (de) Katheter zur gleichmässigen Verteilung von therapeutischen Flüssigkeiten
DE69631531D1 (de) Katheter zur verabreidung von arzneien
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
ATE224189T1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
HK1035315A1 (en) Sterile connector for containers which contain medicinal liquids
BR9906804A (pt) Distribuidor de tratamento de água de derramamento-direto
BR9707210A (pt) Preparado de combinação farmacêutico a partir de análogos de ihrh e antiestrogênios para o tratamento de distúrbios ginecológicos
FR2780974B1 (fr) Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
IT1303805B1 (it) Cotile da revisione per impiego nel trattamento di patologiedell'anca.
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
FR2780892B1 (fr) Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique
ZA962715B (en) Pharmaceutical agents for the treatment of Alzheimer's disease.
PL321630A1 (en) Application of melantonine for treting patients suffering from drug dependence
FR2759906B1 (fr) Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques
FR2727163B1 (fr) Dispositif de dosage et de remplissage notamment pour l'insemination artificielle des especes avicoles et autres applications de dosage et de remplissage
HUP9903679A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
FR2774289B1 (fr) Medicament pour le traitement des dereglements de l'apoptose
FR2758460B1 (fr) Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants
ZA9811787B (en) Novel farnesyl transferase inhibitors, their preparation, pharmaceutical compositions which contain them and their use for the preparation of medicaments.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090331